[Development of new drugs in Nippon (author's transl)].
D000617:Aminoglycosides / Q000494:pharmacology; D000818:Animals; D000900:Anti-Bacterial Agents / Q000494:pharmacology*; D000970:Antineoplastic Agents / Q000494:pharmacology; D002317:Cardiovascular Agents / Q000494:pharmacology; D002511:Cephalosporins / Q000494:pharmacology; D000960:Hypolipidemic Agents / Q000494:pharmacology; D007564:Japan; D004364:Pharmaceutical Preparations; D011619:Psychotropic Drugs / Q000494:pharmacology; D012106:Research
D000617:Aminoglycosides; D000900:Anti-Bacterial Agents; D000970:Antineoplastic Agents; D002317:Cardiovascular Agents; D002511:Cephalosporins; D000960:Hypolipidemic Agents; D004364:Pharmaceutical Preparations; D011619:Psychotropic Drugs
Arzneimette I-Neuentwicklungen in Japan.